For research use only
| Cat No. | ABC-TC0229 |
| Product Type | Equus Caballus Skin Cell Lines |
| Cell Type | Fibroblast |
| Species | Equns Caballus |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Skin |
| Product Code | E.Derm; E. Derm (NBL-6); NBL-6; Eq.Derm; EC1D |
Horse dermis. Derived from a biopsy of a 4 year old mare. These cells have a finite lifespan of a total of 40 passages.
The E.Derm cell line is a finite cell line originally isolated from the dermis of a 4-year-old female Quarter Horse. This cell line exhibits fibroblast-like morphology and adherent monolayer growth properties. The stemline karyotype of E.Derm consists of 64 chromosomes, with a modal range of 52 to 145. E.Derm expresses fibroblast-specific markers, such as vimentin and collagen I. The line is non-tumorigenic in immunodeficient mice, showing no tumor formation after subcutaneous injection, and exhibits no metastatic potential. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | E.Derm; E. Derm (NBL-6); NBL-6; Eq.Derm; EC1D |
| Species | Equns Caballus |
| Cat.No | ABC-TC0229 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Skin |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Equus Caballus Skin Cell Lines |
E.Derm cells serve as a normal equine dermal fibroblast model to study cutaneous wound healing mechanisms and dermatotoxicity. They enable in vitro dermatological drug screening and extracellular matrix remodeling analysis. This system facilitates 3D skin-equivalent tissue engineering and equine-specific inflammatory response modeling, advancing therapeutic development for equine dermatoses and burn rehabilitation.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
